Subsequently, increased TRPV2 expression was also observed in other malignancies like breast cancer, esophageal squamous cell carcinoma, gastric cancer, urothelial cancer and prostate cancer [29, 32–35]. This evidence concerns the gene TRPV2 and prostate carcinoma.